About Us
Medical Blog
  • K2M Obtains Exclusive License to Patent Portfolio

    K2M Group Holdings, Inc. recently announced its acquisition of a portfolio of 17 issued and pending patents for expandable interbody technology.  According to K2M, the company is a global leader in the medical device industry and provides complex spine and minimally invasive solutions to help patients with difficult spinal pathologies achieve three-dimensional (i.e., axial, coronal, and sagittal) ...
  • Excelsius GPSTM: Globus Medical Receives 510(k) Clearance for Robotic Surgery Platform

    Globus Medical announced early today that the Excelsius GPSTM surgical platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as reported by a press release dated August 17, 2017. Globus Medical, which describes itself as a musculoskeletal implant manufacturer, acquired the robotics developer Excelsius Surgical and its robotic guidance device Excelsius GPSTM t ...
  • House Passes Bill Relaxing Reporting Requirements

    The U.S. House of Representatives recently passed the FDA Reauthorization Act of 2017.  This bill seeks to change the requirement for companies to report medical device malfunctions to the FDA.  Previously, companies had to submit a report within 30 days of  a problem.  Under the current version of the Reauthorization Act, companies will be able to submit reports once every three months inst ...
Conferences
  • Sep

    11

    Vascular InterVentional Advances (VIVA)

    Wynn Hotel

    September 11 - 14, 2017

    Las Vegas, NV

    VIVA is the premier global, multidisciplinary course for vascular intervention and medicine. For the past 11 years, VIVA has defined excellence in professional education by offering attendees an innovative, provocative, and balanced educational experience, enhanced by the use of technology and electronic interaction between participants and faculty experts.